Cancers that metastasize or grow in the bone marrow are typically considered incurable and cause extensive damage to the bone and bone marrow. The bone is a complex, dynamic, three-dimensional (3D) environment composed of a plethora of cells that may contribute to, or constrain, the growth of tumor cells and development of bone disease. The development of safe and effective drugs is currently hampered by pre-clinical two-dimensional (2D) models whose poor predictive power does not accurately predict the success or failure of therapeutics. These inadequate models often result in drugs proceeding through extensive pre-clinical studies only to fail clinically. Consistently, 3D co-culture systems prove superior to 2D mono-cultures in modeling in vivo cell phenotypes, disease progression and response to therapeutics. As a complex, multicellular, multidimensional bone microenvironment, 3D models allow for more accurate predictions of tumor growth, cell-cell and cell-matrix interactions, and resulting therapeutic responses. In this review we will discuss various 3D models available and describe step-by-step protocols for two of the most well-established 3D culture models for studying tumor-induced bone disease.
Introduction
Despite decades of research in pathologies caused by bone metastatic tumors (breast, prostate, renal and lung), multiple myeloma (MM) and primary bony invasive tumors (osteosarcoma, oral cancer and melanoma), tumor-induced bone disease continues to be a clinical problem that causes pain and increased fracture risk in patients. 1 The lack of models that accurately mimic the complexity of the bone, whereas allowing for detailed molecular analysis, has been a major obstacle for progress. Thus, many groups have developed 3D models to enable longitudinal investigation of fundamental cell-cell and cell-matrix interactions in the complex cancer microenvironment over time.
Biomimetic 3D tissue-engineered systems have been developed for numerous diseases, but the complexity of bone has caused a lag in the development of appropriate 3D bone models. When developing 3D models of bone and cancer, many parameters are important including the strength, pore size, mineral composition and fluid flow, which are significantly different in the bone than any other tissue in the body. It is critical to accurately mimic these conditions as it has been demonstrated that matrix rigidity influences cancer invasion, metastasis and tissue tropism. [2] [3] [4] [5] Furthermore, other studies have demonstrated that the extreme rigidity of bone helps promote stem cell differentiation 6 and increases osteoblast differentiation and mineralization, 7 suggesting that a 3D bone mimicking microenvironment is not only critical for studying tumor behavior in bone, but also for studying the contribution of other cells present in the bone and bone marrow (BM). In Table 1 , different types of tissue-engineered bone biomaterials are summarized with a list of their compressive strength, as this is a key parameter useful for comparing 3D tissue-engineered bone. (For a review on methods for analyzing mechanical properties of 3D tissue engineering materials, please see ref. 8) .
In this review, we will provide an overview of techniques currently available to study tumor interactions with bone in utilizing 3D models.
3D Models using Naturally Derived Materials
Decellularized Bone and Matrix. Decellularized bone modeling involves decellularizing native bone tissue via chemical, enzymatic, physical or combination treatments 9, 10 and has recently been explored for developing in vitro cancer-and-bone models. 11 These models circumvent immunogenicity caused by xenografts, mimic bone structure and microarchitecture, and offer cells a tissue-appropriate template. A recent tissueengineered model of Ewing's sarcoma describes the differential gene expression of tumor cells in 3D which results in strong upregulation of cancer-related genes, expression of hypoxic and glycolytic tumor phenotypes, and angiogenic and vasculogenic mimicry. 12 Similarly, BM and adipose-derived (AD) stromal cells have been used to generate BM-extracellular matrix (ECM) and AD-ECM, which is subsequently decellularized and seeded with specific cells of interest. 13 Although both ECMs supported proliferation of cancer cell lines (HeLa, MCF-7 and MDA-MB-231), and mesenchymal stromal cells (MSCs), they showed differences in architecture (that is, fiber orientation, surface roughness) and physical properties (storage modulus and surface energy). 13 It is debatable whether culturing on ECM is truly a 3D culture, as the tumor cells still grow in a relatively flat plane.
Hyaluronic Acid Hydrogels. Another natural 3D bone model uses hyaluronic acid-based hydrogels seeded with renal cell carcinoma cells, which form spheroids in hydrogels, proliferate more slowly, and more accurately mimic in vivo gene expression and cell phenotype than when grown in 2D. 14 A similar system uses prostate cancer osteoblast co-cultures in a hydrogel composed of thiolated hyaluronic acid and acrylated functionalized peptides with GRGDS integrin-binding sites and MMP-cleavable sites. 15 These models have allowed for visualization of osteoblasts (MC3T3-E1 cells) wrapping around tumoroids in co-culture. 15 However, hyaluronic acid hydrogel compressive moduli are around 9.3 kPa, or up to 22.6 kPa when crosslinked with genipin. 16 These values do not accurately mimic bone material properties and may cause tumor cell behavior that is not reflective of the native bone microenvironment. Many other material composite hydrogels of hyaluronic acid with gelatin, agarose, alginate and polyethylene glycol-g-chitosan have also been developed and described; these all remain below the 25 kPa compressive modulus range. 17 Silk Protein. Silk fibroin is a highly versatile, biocompatible and biodegradable natural biopolymer. Highly porous (B50-500 mm pore size), cell-supporting silk scaffolds provide a 3D microenvironment for cell attachment, growth and co-culture for tumor cells. 18, 19 Successful cancer-and-bone models have been demonstrated with MM cells that typically are not able to survive culture in 2D in vitro, but can be cultured for 2 weeks on Bombyx mori silk fibroin scaffolds. 18 Breast and prostate cancer cells also survive culture for up to 30 days on Antheraea mylitta silk scaffolds. 12, [18] [19] [20] [21] Silk scaffolds can be either hexafluoroisopropanol (HFIP)-derived (85-1000 kPa alone to 10.64 MPa when reinforced with silk fibers) 22 or aqueous-derived (50 kPa-3.33 MPa), depending on the formulation process. 23, 24 Aqueous scaffolds may better promote MSC adhesion owing to their rougher surface texture, higher modulus and more microporous topography. 24, 25 Aqueous-based scaffolds also appear to Decellularized ECM from cultured cells NA 11, 13 Decellularized bone (with tumor cell lines or cell spheroids) 125-145 MPa 9, 10, [44] [45] [46] Cell sheets in bioreactors on cellulose membranes NA 47 Cell sheets over medical-grade polycaprolcatone-tricalcium phosphate scaffolds Unknown 48 Hyaluronic acid-based hydrogels 9.3-20 kPa 16 Silk fibroin scaffolds Varies, B13 MPa 22 before cell-based mineralization 18, 20, 22, [49] [50] [51] [52] HA (with or without with collagen I peptides) Unreported, or B5.5 kPa: HA þ collagen B3.24 kPa: collagen 14, 15, 32, 53, 54 Chitosan hydrogel scaffolds (with or without HA or collagen) B5 kPa 55, 56 Fibronectin/collagen I/matrigel B2 kPa 57, 58 Aqueous-derived silk scaffolds 3. Tissue-engineered 3D bone-cancer models U Dadwal et al support greater bone formation in vitro and degrade faster in vivo than HFIP-derived scaffolds. 26 In the following protocols, we discuss processes for making silk scaffolds, and methods for utilizing silk scaffolds for 3D in vitro cancer-and-bone models.
Composites and Other Materials. Although not specifically used for bone/cancer models, many other natural materials could also be used for this application. For example, a mechanically stiff, zinc crosslinked nanocomposite scaffold with osteoinductive properties was recently described using natural, biodegradable gellan and xanthan polymers reinforced with 20-120 nm-sized bioglass nanoparticles. 7 Their compressive strength and modulus, 1.91±0.31 MPa and 20.36±1.08 MPa, respectively, were comparable to the trabecular bone and very high compared with nanocomposite scaffolds reported in earlier studies. 7 Porous S-sulfo keratin sponge scaffolds have also been fabricated, but their compressive strengths are unknown. 27
3D Models using Synthetic Materials
The bone is a dichotomous tissue with a spongy marrow interior and a strong, rigid exterior. The rigid bone matrix can be mimicked by a range of synthetic materials including bioactive glass, calcium phosphates and polymer/ceramic composites, which offer robust control over structural and mechanical properties.
PURs. Polyurethanes (PURs), which are synthesized from the reaction of isocyanates (hard segment) with hydroxyls (soft segment), have been extensively used as bone and vascular grafts, and in medical devices. They are tough, durable and non-cytotoxic with tunable mechanical properties and degradation rates. PURs can be electrospun, solvent-cast or molded into defined architectures. 28 PUR scaffolds have been used to study osteogenic differentiation, 29 wound healing 30 and regeneration in the context of the bone. 31 Although 3D printing or additive manufacturing (AM) approaches, such as Fused Deposition Modeling (FDM), enable precise control over topological properties, the limited number of materials that can be processed by AM techniques precludes precise control over mechanical properties. Below we provide methods for fabricating 3D scaffolds with substrate moduli ranging from that of collagen to trabecular bone (10-300 MPa), and pore sizes in the range that support tumor proliferation and modulate gene expression associated with metastatic disease (4300 mm) using a t-FDM process. 29 Poly(lactide-co-glycolide). Other synthetic materials for cancer-and-bone models include porous mineralized scaffolds composed of poly(lactide-co-glycolide) and hydroxyapatite (HA). 32 These are fabricated by a modified gas-forming/ particulate-leaching method 33 and have a compressive modulus of 1.1 MPa. HA, the primary constituent of inorganic matter in the bone, is noted for its role in providing bone with exceptional tissue stiffness and serving as a reservoir of ions (that is, Ca 2 þ and PO 4 3 À ). It also represents a bioactive material that modulates the behavior of both normal and tumor cells independent of changes in material properties. 32 Bioglass. Bioglass known as 63 s glass (63% SiO 2 , 28% CaO and 9% P 2 O 5 in molar percentages) has been used as a starting material for bone-cancer in vitro scaffold models. 34 It has been reinforced with HA nanowhiskers (500 nm length and 50 nm aspect ratio) or nanoparticles (100 nm diameter) 34 that significantly increase compressive strength and fracture toughness when compared with pure 63 s glass scaffolds. Bioglass composite scaffolds successfully cultured MG-63 osteosarcoma cells and exhibited good apatite-forming ability and cellular affinity. 34 PLLA/b-TCP. Nanocomposite scaffolds have also been made using b-tricalcium phosphate (b-TCP) nanoparticles incorporated into poly(L-lactic acid) (PLLA) using a thermally induced phase-separation method. 35 These scaffolds with interconnected micropores utilize the good osteoconductive and osteoinductive properties of b-TCP and the biogradation abilities of PLLA. 35 MG-63 osteosarcoma cells also proliferated well on these scaffolds. 35 Fabrication methods and protocol details Several aspects must be considered and individualized for each study when choosing a 3D model. As described above, these parameters include matrix rigidity, chemistry, pore size and availability of tools. Here, we describe two protocols to fabricate 3D models using 'natural' and 'synthetic' materials. Silk scaffolds are excellent models to use to investigate long term (14-30 days) co-culture interactions between the bone microenvironment cells and tumor cells (for example, MM, prostate and breast cancer cells). They are highly porous, biocompatible and biodegradable. 3D-printed PUR-templated fusion deposition (see the section 't-FDM Scaffold Fabrication and Seeding for Tissue-Engineered Bone' below) are outstanding models for studying structural properties of the bone (microarchitecture, pore size, rigidity, shear stress and fluid flow) and its impact on metastatic gene expression and morphology of tumor cells (mono-and co-cultures) for both short-and long-term cultures. Both silk and printed PUR template fusion deposition scaffolds are mechanically tunable, biocompatible, and have a controllable and well-defined microarchitecture (pore sizes and scaffold shape).
Silk Scaffold Fabrication and Seeding for Tissue-Engineered Bone.
Aqueous-and HFIP-derived silk scaffolds. Silk fibroin scaffolds are fabricated using silkworm (Bombyx mori) cocoons (Figures 1a-h) . In all, 5 g of silkworm cocoons are cut into small pieces, placed into 2 l of boiling 0.02 M Na 2 CO 3 , and boiled for 30 min. The supernatant containing silk sericin is discarded, and silk fibroin is retained and rinsed in fresh de-ionized water for 20 min 3 times. The silk is wrung out and laid to dry. In a beaker, a 9.3 M solution of LiBr is added to dried silk (20% weight silk/volume LiBr), covered and allowed to dissolve at 60 1C for 4 h. Dialysis cassettes (3500 MW cutoff) are filled with 12 ml of silk LiBr solution, which is dialyzed against 1 l de-ionized water for 3 days. The silk solution is then centrifuged for 20 min (9000 r.p.m., 5-10 1C) twice to remove debris and concentration is determined (wt/wt% or wt/vol%) by weighing a 1 ml sample 'of the solution before and after drying for 12 h at 60 1C. Silk solutions of 6-8% work well for constructing scaffolds of 500-600 mm pore sizes.
Tissue-engineered 3D bone-cancer models U Dadwal et al Figure 1 Generation, seeding and analysis of silk scaffolds for tissue-engineered bone-cancer models. (a) Silk worms (Bombyx mori) are grown on mulberry leaves and produce cocoons as they begin to undergo metamorphosis into silk moths. (b) Cleaned cocoons are boiled to separate silk sericin from silk fibroin and air dried to produce fibroin with a cottony texture. (c) Dried silk fibroin is then dissolved in LiBr to produce a highly concentrated silk solution. (d) This solution is then dialyzed with dialysis cassettes to remove LiBr ions and purify the silk solution. Silk solution can then be freeze-dried and re-dissolved by HFIP, or used directly to make silk scaffolds. (e) Silk solution is poured into molds and NaCl crystals are added slowly over the silk solution to crosslink silk protein to create a porous scaffold. After 3 days, salt is washed from the scaffolds and scaffolds are cut to size. (f) Silk scaffolds can be imaged with a scanning electron microscope (SEM) for high-resolution imaging. (g) Schematic of silk scaffolds making procedures. (h) Scaffolds are soaked in well plates (top) with culture media to prepare for seeding, and then cells are seeded with a pipette (bottom). (i) Whole flushed BM cells from C3H mice were seeded onto silk scaffolds and imaged with live/dead confocal imaging 3 days after seeding. (1) Silk autofluorescence is seen in the blue channel, dead cells (ethidium homodimer-1) and autofluorescence of silk is seen in the red channel, and live cells (calcein) are seen in the green channel. (2) Magnification of the overlay from shows scaffold in purple/pink, live cells in green, and a few dead cells, indicated in red. (3) Live-dead (calcein-green/ethidium homodimer-1/red) staining confocal imaging of mouse MSCs (green) first expanded in vitro on tissue culture plastic (2D), and then seeded at passage 2 on silk scaffolds (red) and cultured for 9 days in mMSC expansion media. Cells can be seen growing off the scaffolds and into the pores throughout the scaffolds.
Tissue-engineered 3D bone-cancer models U Dadwal et al
Aqueous-Derived Silk Fibroin Scaffold Preparation In all, 4 g of NaCl particles sifted through a metal mesh to obtain desired pore size (500-600 mm diameter) are slowly added to 2 ml silk fibroin aqueous solution in plastic containers. Containers are covered, sealed airtight and left at room temperature (RT) for 24 h prior to immersion in de-ionized water for 2 days to extract NaCl. HFIP-Derived Silk Fibroin Scaffold Preparation To lyophilize silk, silk fibroin aqueous solution is pour into a 50 ml conical tube, covered with a Kimwipe secured with a rubber band and frozen at À 80 1C overnight or until fully dried. Lyophilized silk is then dissolved with HFIP to produce a 17 wt% HFIP-derived silk solution in a chemical hood. HFIP silk solution (2 ml) is poured over 4 g of NaCl particles (500-600 mm diameter) in small plastic containers, which are capped quickly and left overnight at RT. Containers are opened to allow HFIP to evaporate from scaffolds for 3 days then submerged in a 90% methanol solution for 30 min to 3 days to induce b-sheet structure formation.
Finally, samples are removed and immersed in water for 3 days to remove NaCl particles to produce silk scaffolds, which are removed from containers and cut to shape. Tissue-engineered 3D bone-cancer models U Dadwal et al allow cells to adhere to scaffold and then fresh media is added to cover the scaffolds. At day 5, or once scaffolds appear covered by hMSCs, osteogenic medium is added to scaffolds and cells are differentiated for as long as desired to create TE-bone (tissue-engineered bone). If tumor cells are cultured with TE-bone during or after the process of differentiation, dexamethasone should not be used in media and an alternative acceptable medium for both cell types should be determined. Medium is changed every 3 days, or as often as needed.
Mineralization can be quantified with mCT or histology. For hMSCs, 1 week of proliferation and 3-4 weeks of osteogenic differentiation produces mineralized, osteoblast-containing scaffolds, depending on the cell donor. Materials and Methods. Glycerol is dried at 10 mm Hg overnight at 80 1C and e-caprolactone is dried over anhydrous magnesium sulfate prior to use (B15 min). Poly(e-caprolactone-coglycolide) triol (M n ¼ 3000 g mol À 1 ) is synthesized using the glycerol starter, e-caprolactone, D,L lactide, glycolide and catalyst-stannous octoate mixed in a 100-ml reaction flask with mechanical stirring under argon for 36 h at 140 1C. The polyol then is dried under vacuum at 80 1C for 14 h. PUR scaffolds are synthesized by mixing poly(e-caprolactone-coglycolide) triol (M n ¼ 300 (add 1.98 g) or 3000 g mol À 1 (add 3.15 g)), hexamethylene diisocyanate trimer (HDIt (Bayer MaterialScience, Pittsburgh, PA, USA), (add 4 g (for M n ¼ 300) or 1.5 g (for M n ¼ 3000), respectively)) and stannous octoate (catalyst, (add 1.2 mg)) in a cup for 30 s with a Hauschild SpeedMixer DAC 150 FVZ-K vortex mixer (FlackTek, Landrum, SC, USA). This solution is then poured into the PLA templates as described below.
Fabrication of 3D scaffolds by templated-fused deposition modeling. Polylactic acid (PLA) template molds can be designed with varying internal microarchitecture, shape and size. For this example, we designed scaffold mold templates (14 mm diameter) with a defined 100% connected porous architecture using SolidWorks software (Waltham, MA, USA) and printed using a MakerBot Replicator 2 FDM printer (Brooklyn, NY, USA) ( Figure 2) . The PUR liquid is poured into the PLA templates to completely cover them (B500 mg) and cured at 60 1C overnight. The PLA template is then immersed in acetone (B2 h), leached with dichloromethane (use 2 Â volume of the scaffolds or enough to immerse all the scaffolds), washed with acetone and then dichloromethane to yield scaffolds with interconnected pores having a channel diameter of 423±34 or 557 ± 44 mm for nominal 300 or 500 mm templates, respectively 29 (Figures 2a-d) . Scaffolds are sterilized under ultraviolet light for 15 min in 70% ethanol, rinsed with phosphate-buffered saline (three times) and then placed in a solution of 4 mg ml À 1 fibronectin overnight at 4 1C. The substrate modulus (E s ) of the scaffolds is controlled by the M w of the polyester triol (compliant, 3000 g mol À 1 ; rigid, 300 g mol À 1 ) to attain values representative of collagen (5 MPa, compliant) , trabecular bone (266 MPa, rigid) or cortical bone (871-11 500 MPa). 36, 37 Cell viability, proliferation and metabolic activity. Trypan Blue cell viability, live/dead staining (calcein/propidium homodimer) or MTS assays (CellTiter 96 Aqueous Non-Radioactive Cell Proliferation Assay, Promega, Madison, WI, USA) can be performed as per the manufacturers' protocols.
Bioreactor experiments. Scaffolds are cultured in a flow perfusion bioreactor (3D Biotek, North Brunswick Township, NJ, USA). During bioreactor culture, scaffolds can be placed in individual autoclavable polycarbonate chambers and seeded with 0.25 to 1 Â 10 6 GFP þ MDA-MB-231 cells per scaffold. These scaffolds then can be studied simultaneously using a steady flow regime for 48 h at 9.35 ml s À 1 (an optimal flow rate for MDA-MB-231 cells). This flow rate equates to osteogenic inductive fluid shear stress, t (B0.0176 Pa). 38, 39 Culture medium (either standard or supplemented with study drugs) is perfused through the open porous structure of scaffolds using a pulsatile pump feeding into a media reservoir chamber. Within each chamber there is a 1.5 mm distance separating each scaffold. The whole system, including the pump, is placed in a 5% CO 2 , 37 1C incubator. After culture scaffolds are harvested for gene or protein expression.
Analysis Protocols. Both silk scaffolds and PUR 3D-printed scaffolds can be imaged or analyzed with confocal microscopy (Figures 1i and 2f) , flow cytometry to measure changes in cell populations, immunohistochemistry, scanning electron microscopy and bioluminescence imaging. These procedures require little modification from typical protocols, and thus will not be discussed here.
Cell isolation from scaffolds for downstream analysis. Cells are trypsinized from scaffolds, and fluorescence is used to quantify and separate cells into different populations when needed. Scaffolds are flash frozen in liquid nitrogen and then crushed using a mortar and pestle to extract cells for mRNA or microRNA expression from total RNA using Qiagen miRNeasy Kits (Qiagen, Hilden, Germany).
Immunohistochemistry. After desired co-culture period, silk scaffolds can be fixed in 4% paraformaldehyde overnight, paraffin embedded and stained for markers such as alizarin red (mineralization), hematoxylin and eosin or immunohistochemisty for proteins of interest, such as CD138 in myeloma. For histological assessment of in vivo 3D-printed scaffolds, animals are killed, and these scaffolds can be excised and processed using paraffin embedding. When sectioning scaffolds, keep paraffin block cold by placing on ice. Ensure the microtome blade is sharp and kept clean as not to snag and tear the section. After placing the section on slide make certain the section is placed firmly on the slide. Leave the slides to dry overnight at room temperature or for B8 h on a slide warmer.
Cell sources hMSCs, mouse MSCs or osteoblast lineage cell lines are seeded onto scaffolds and tumor cells are added when desired. Alternatively, whole BM can be directly seeded onto scaffolds ( Figure 1) using previously published methods. 18, 40 Human BM cell source Human stromal cells are isolated fresh from BM as previously described. 18 Briefly, 25 ml BM is spun at 1200 r.p.m. for 5 min at 4 1C and then gently removed from centrifuge. BM adipose is congealed at the top of this liquid, which should be aspirated using low suction without disturbing the marrow. BM is transferred to a larger flask, mixed with 224 ml hMSC expansion media, and evenly distributed to 14 deep T-185 flasks (20 ml per flask). Flasks are rocked daily. Medium (20 ml) is added to flasks every 3 days for 9 days, removing nothing. At day 10, adherent colonies are analyzed under a microscope for confluency. Alternatively, there are many commercial sources of mouse and human BM and purified MSCs.
Conclusions
In this article, we described the methods necessary for developing and validating a variety of tissue engineering models for cancer-and-bone interactions. There is an urgent need to develop and validate reliable in vitro models to reproduce specific tissue-like structures and mimic functions and responses of tissues in a physiological manner. These models must be physiologically relevant 3D platforms to bridge the gap between 2D and in vivo animal model-based cancer research. Indeed, over the past two decades, accumulating evidence about various organs and disease models has demonstrated that the biochemically and spatially defined network of ECM, cellular components, and interactions that dictate cell differentiation, proliferation and function in vivo are lost in simplified 2D conditions, but captured with 3D models. 41 For example, the substrate modulus of the tissue surrounding a tumor significantly affects tumor cell behavior, gene expression, phenotype and invasion potential. 37, 42 3D models can thus accelerate the translation from pre-clinical to clinical trials by more accurately predicting disease course, responsive subpopulations or treatment responses, especially when using humanized, engineered bone rather than mouse bone. The protocols and methods summarized here are some of the best available tools for modeling tumors within the BM. These models have the potential to support personalized medicine through patient specific model development. Finally, the models described here enable screening of new therapeutics in a dynamic in vitro system prior to pre-clinical testing to allow for investigation of effects on tumor cells and microenvironmental cells.
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